REMIX THERAPEUTICS Trademark
Trademark Overview
On Monday, September 25, 2023, a trademark application was filed for REMIX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REMIX THERAPEUTICS trademark a serial number of 98195999. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 24, 2024. This trademark is owned by Remix Therapeutics Inc.. The REMIX THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for the use in gene therapy for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respir...
development of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation
General Information
Serial Number | 98195999 |
Word Mark | REMIX THERAPEUTICS |
Filing Date | Monday, September 25, 2023 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Thursday, October 24, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
Description of Mark | The mark consists of design of sound waves in shades of blue and green preceding the literal elements appearing in dark green REMIX and THERAPEUTICS with REMIX appearing above THERAPEUTICS. |
Goods and Services | Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for the use in gene therapy for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; preparations for detecting mutation in RNA genes for medical purposes |
Indication of Colors claimed | The color(s) blue and green is/are claimed as a feature of the mark. |
NOT AVAILABLE | THERAPEUTICS |
Goods and Services | development of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 26, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 26, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Remix Therapeutics Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02139 |
Trademark Events
Event Date | Event Description |
Tuesday, October 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, October 11, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, May 16, 2024 | ASSIGNED TO EXAMINER |
Friday, May 17, 2024 | NON-FINAL ACTION WRITTEN |
Friday, May 17, 2024 | NON-FINAL ACTION E-MAILED |
Friday, May 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, June 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, June 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, June 27, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, June 27, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, June 27, 2024 | NON-FINAL ACTION WRITTEN |
Monday, September 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, September 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, September 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, October 3, 2024 | FINAL REFUSAL E-MAILED |
Thursday, October 3, 2024 | FINAL REFUSAL WRITTEN |
Thursday, October 3, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Monday, October 21, 2024 | EXAMINER'S AMENDMENT ENTERED |
Monday, October 21, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Monday, October 21, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, October 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, October 21, 2024 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |